Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Plinio Cirillo

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
The American Journal of Cardiology|May 12, 2018
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK StudyFederica Ilardi, Giuseppe Gargiulo, Gabriele Giacomo Schiattarella, et al.
International Journal of Cardiology|October 25, 2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registryArturo Cesaro, Felice Gragnano, Paolo Calabrò, et al.
Cardiovascular Research|July 19, 2005
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationPlinio Cirillo, Paolo Golino, Paolo Calabrò, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions|October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
International Journal of Cardiology|September 2, 2018
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI studyLeonardo De Luca, Federico Piscione, Furio Colivicchi, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2018
Lights and shadows of long-term dual antiplatelet therapy in "real life" clinical scenariosMarino Scherillo, Plinio Cirillo, Dario Formigli, et al.
The Journal of Invasive Cardiology|February 29, 2024
A comparison between radial artery compression devices for patent hemostasis after transradial percutaneous interventionsLuigi Di Serafino, Maurizio Turturo, Claudio Larosa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trialRaffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento, et al.
Internal and Emergency Medicine|June 20, 2020
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registryFelice Gragnano, Elisabetta Moscarella, Paolo Calabrò, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|May 12, 2018
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK StudyFederica Ilardi, Giuseppe Gargiulo, Gabriele Giacomo Schiattarella, et al.
International Journal of Cardiology|October 25, 2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registryArturo Cesaro, Felice Gragnano, Paolo Calabrò, et al.
Cardiovascular Research|July 19, 2005
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationPlinio Cirillo, Paolo Golino, Paolo Calabrò, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions|October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
International Journal of Cardiology|September 2, 2018
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI studyLeonardo De Luca, Federico Piscione, Furio Colivicchi, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2018
Lights and shadows of long-term dual antiplatelet therapy in "real life" clinical scenariosMarino Scherillo, Plinio Cirillo, Dario Formigli, et al.
The Journal of Invasive Cardiology|February 29, 2024
A comparison between radial artery compression devices for patent hemostasis after transradial percutaneous interventionsLuigi Di Serafino, Maurizio Turturo, Claudio Larosa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trialRaffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento, et al.
Internal and Emergency Medicine|June 20, 2020
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registryFelice Gragnano, Elisabetta Moscarella, Paolo Calabrò, et al.
Pageof 17